It is what is not happening that is the problem. A bit harder to prove but not researching antibiotics is one case that is widely discussed. A google search on

It is what is not happening that is the problem. A bit harder to prove but not researching antibiotics is one case that is widely discussed. A google search on "why aren't drug companies researching antibiotic drugs" brings up lots of articles spanning decades. This Business Insider [1] article is quite recent. Here is a quote from that article: "The costs to develop a new antibiotic drug are no less expensive compared to development of drugs for other therapeutic areas, yet the commercial potential and return on investment for companies developing new antibiotics are significantly lower than drugs to treat chronic conditions such as diabetes or heart disease," said Gary Disbrow, deputy director of the Biomedical Advanced Research and Development Authority, which sits within the U.S. Department of Health and Human Services. [1]https://www.businessinsider.com/major-pharmaceutical-companies-dropping-antibiotic-projects-superbugs-2018-7 https://www.businessinsider.com/major-pharmaceutical-compani...